ZANOTTI, LAURA
ZANOTTI, LAURA
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Mineralocorticoid Receptor Antagonism Prevents Type 2 Familial Partial Lipodystrophy Brown Adipocyte Dysfunction
2023 Schena E.; Mattioli E.; Peres C.; Zanotti L.; Morselli P.; Iozzo P.; Guzzardi M.A.; Bernardini C.; Forni M.; Nesci S.; Caprio M.; Cecchetti C.; Pagotto U.; Gabusi E.; Cattini L.; Lisignoli G.; Blalock W.; Gambineri A.; Lattanzi G.
Androgens and Severe Insulin Resistance States: Basic and Clinical Aspects
2019 Gambineri A.; Zanotti L.; Ibarra-Gasparini D.
Polycystic ovary syndrome in familial partial lipodystrophy type 2 (FPLD2): basic and clinical aspects
2018 Gambineri, Alessandra; Zanotti, Laura
Defining hyperandrogenism in women with polycystic ovary syndrome: A challenging perspective
2016 Pasquali, Renato; Zanotti, Laura; Fanelli, Flaminia; Mezzullo, Marco; Fazzini, Alessia; MORSELLI LABATE, ANTONIO MARIA; Repaci, Andrea; Ribichini, Danilo; Gambineri, Alessandra
Psychological aspects of hyperandrogenic states in late adolescent and young women.
2015 Guidi, J; Gambineri, A; Zanotti, L; Fanelli, F; Fava, Ga; Pasquali, R
Parallel variations of insulin-like peptide 3 (INSL3) and antimüllerian hormone (AMH) in women with the polycystic ovary syndrome according to menstrual cycle pattern.
2013 Pelusi C;Fanelli F;Pariali M;Zanotti L;Gambineri A;Pasquali R
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Mineralocorticoid Receptor Antagonism Prevents Type 2 Familial Partial Lipodystrophy Brown Adipocyte Dysfunction | Schena E.; Mattioli E.; Peres C.; Zanotti L.; Morselli P.; Iozzo P.; Guzzardi M.A.; Bernardini C....; Forni M.; Nesci S.; Caprio M.; Cecchetti C.; Pagotto U.; Gabusi E.; Cattini L.; Lisignoli G.; Blalock W.; Gambineri A.; Lattanzi G. | 2023-01-01 | CELLS | - | 1.01 Articolo in rivista | Mineralocorticoid Receptor Antagonism Prevents Type 2 Familial Partial Lipodystrophy Brown Adipocyte Dysfunction.pdf; cells-12-02586-s001.zip |
| Androgens and Severe Insulin Resistance States: Basic and Clinical Aspects | Gambineri A.; Zanotti L.; Ibarra-Gasparini D. | 2019-01-01 | - | Ezio Ghigo | 2.01 Capitolo / saggio in libro | FHR494911AuthorProof.pdf |
| Polycystic ovary syndrome in familial partial lipodystrophy type 2 (FPLD2): basic and clinical aspects | Gambineri, Alessandra; Zanotti, Laura | 2018-01-01 | NUCLEUS | - | 1.01 Articolo in rivista | - |
| Defining hyperandrogenism in women with polycystic ovary syndrome: A challenging perspective | Pasquali, Renato; Zanotti, Laura; Fanelli, Flaminia; Mezzullo, Marco; Fazzini, Alessia; MORSELLI ...LABATE, ANTONIO MARIA; Repaci, Andrea; Ribichini, Danilo; Gambineri, Alessandra | 2016-01-01 | THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM | - | 1.01 Articolo in rivista | - |
| Psychological aspects of hyperandrogenic states in late adolescent and young women. | Guidi, J; Gambineri, A; Zanotti, L; Fanelli, F; Fava, Ga; Pasquali, R | 2015-01-01 | CLINICAL ENDOCRINOLOGY | - | 1.01 Articolo in rivista | - |
| Parallel variations of insulin-like peptide 3 (INSL3) and antimüllerian hormone (AMH) in women with the polycystic ovary syndrome according to menstrual cycle pattern. | Pelusi C;Fanelli F;Pariali M;Zanotti L;Gambineri A;Pasquali R | 2013-01-01 | THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM | - | 1.01 Articolo in rivista | - |